Compared with the negative control group, the inhibition rate of tumor growth in the group of ds-Diabody against bFGF could reach 86.54%, while the group of the full-length human IgG against bFGF was about 29.46% (Figure 8d). The gene discussed is FGF2; the disease is neoplasm.